| For: | Bharaj IS, Brar AS, Kahlon J, Singh A, Hotwani P, Kumar V, Sohal A, Batta A. Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis. World J Cardiol 2025; 17(6): 106147 [PMID: 40575425 DOI: 10.4330/wjc.v17.i6.106147] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v17/i6/106147.htm |
| Number | Citing Articles |
| 1 |
Inderjeet Singh Bharaj, Ajit Brar, Aayushi Kacheria, Karen Purewal, Austin Simister, Umabalan Thirupathy, Palak Gupta, Jasraj Kahlon, Juzer Munaim, Ei Ei Thwe, Samer Ibrahim, Valerie Martinez Vargas, Krishnaswami Vijayaraghavan. Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo. Biomedicines 2025; 13(9): 2192 doi: 10.3390/biomedicines13092192
|
| 2 |
Yao Zhang, JiaXin Qi, Xia Chen, Lin Pang, Zhangwei Shi, Bowen Wei, Cheng Lian. Atrial fibrillation identification in patients with non-alcoholic fatty liver disease: a machine learning model based on immune-inflammatory markers. Diabetology & Metabolic Syndrome 2025; doi: 10.1186/s13098-025-02025-8
|
| 3 |
Agata Morawska, Rafał Frankowski, Mikołaj Grabarczyk, Marcin Kosmalski, Monika Różycka-Kosmalska. Crosstalk Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Atrial Fibrillation: Shared Mechanism, Diagnostic Integration, and Management Implications. Life 2025; 15(11): 1713 doi: 10.3390/life15111713
|
| 4 |
Carlo Ratti, Mattia Malaguti, D'Aniello Emanuele, Antonio Bellasi, Gianluca Sanna. Understanding MASLD — from molecular pathogenesis to cardiovascular risk: A concise review for the clinical cardiologist. Atherosclerosis 2025; 409: 120495 doi: 10.1016/j.atherosclerosis.2025.120495
|
